Literature DB >> 1587396

Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats.

R J Jacob1, R S Sherwin, K Greenawalt, G I Shulman.   

Abstract

It has recently been shown that the ability of insulinlike growth factor I (IGF-I) to stimulate glucose uptake and to lower circulating amino acid levels is retained in insulin-resistant diabetic BB rats. To examine in vivo effects of IGF-I in obese Zucker rats (another model of insulin resistance) 6 obese and 6 lean rats received euglycemic IGF-I infusions (0.65 nmol.kg-1.min-1). IGF-I-stimulated glucose uptake in obese rats was 50% lower than lean control rats (45.0 +/- 2.8 vs. 92.2 +/- 6.1 mumol.kg-1.min-1, respectively), even though the rise in circulating IGF-I levels was greater in the obese group during IGF-I infusion. In addition, branched chain amino acid concentrations that declined by 45% in lean controls were not suppressed significantly in obese rats (392 +/- 33 basal vs. 327 +/- 29 microM at 90 min). Equivalent results were observed during euglycemic insulin clamps (12 pmol.kg-1.min-1) in 7 obese and 11 lean rats. These studies demonstrate that obese Zucker rats are resistant to the effects of IGF-I and insulin on glucose and amino acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587396     DOI: 10.2337/diab.41.6.691

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

Review 2.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.

Authors:  G Di Cola; M H Cool; D Accili
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.

Authors:  Brian D Piccolo; James L Graham; Kimber L Stanhope; Oliver Fiehn; Peter J Havel; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-04-19       Impact factor: 4.310

5.  Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  R Laager; U Keller
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.